Announcements Trials

Browse Landscape

Sponsor Class

Sponsor

Interventions

Specimen Handling 5 X-Rays 3 Magnetic Resonance Spectroscopy 3 Immunoglobulin G 3 Disulfides 3 pembrolizumab 2 cabozantinib 2 Taxes 2 Sunitinib 2 Rituximab 2 Phantoms, Imaging 2 Paclitaxel 2 Nivolumab 2 Cyclophosphamide 2 Carboplatin 2 CT-P10 2 Biopsy 2 Bevacizumab 2 ulixertinib 1 trastuzumab biosimilar HLX02 1 trametinib 1 sapanisertib 1 relatlimab 1 prednylidene 1 pertuzumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 pegaspargase 1 palbociclib 1 osimertinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

NIH × Has announcements × continuous erythropoietin receptor activator × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡